164 related articles for article (PubMed ID: 12944527)
1. Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain.
Wang Y; Chang CF; Morales M; Chiang YH; Harvey BK; Su TP; Tsao LI; Chen S; Thiemermann C
J Neurosci; 2003 Aug; 23(21):7958-65. PubMed ID: 12944527
[TBL] [Abstract][Full Text] [Related]
2. Effects of adenosine 5'-triphosphate, uridine 5'-triphosphate, adenosine 5'-tetraphosphate and diadenosine polyphosphates in guinea-pig taenia caeci and rat colon muscularis mucosae.
Hourani SM; Bailey SJ; Johnson CR; Tennant JP
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):464-73. PubMed ID: 9826069
[TBL] [Abstract][Full Text] [Related]
3. Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration.
Harvey BK; Chou J; Shen H; Hoffer BJ; Wang Y
Neurotoxicology; 2009 May; 30(3):436-44. PubMed ID: 19442829
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
[TBL] [Abstract][Full Text] [Related]
5. Diadenosine polyphosphates evoke Ca2+ transients in guinea-pig brain via receptors distinct from those for ATP.
Pintor J; Puche JA; Gualix J; Hoyle CH; Miras-Portugal MT
J Physiol; 1997 Oct; 504 ( Pt 2)(Pt 2):327-35. PubMed ID: 9365907
[TBL] [Abstract][Full Text] [Related]
6. The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates.
Hoyle CH; Ziganshin AU; Pintor J; Burnstock G
Br J Pharmacol; 1996 Jul; 118(5):1294-300. PubMed ID: 8818356
[TBL] [Abstract][Full Text] [Related]
7. Diadenosine tetraphosphate (Ap
Reigada D; Navarro-Ruiz RM; Caballero-López MJ; Del Águila Á; Muñoz-Galdeano T; Maza RM; Nieto-Díaz M
Purinergic Signal; 2017 Mar; 13(1):75-87. PubMed ID: 27761681
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway.
Xu L; Chen WF; Wong MS
Br J Pharmacol; 2009 Oct; 158(3):738-48. PubMed ID: 19703168
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats.
Wang Y; Chang CF; Morales M; Chou J; Chen HL; Chiang YH; Lin SZ; Cadet JL; Deng X; Wang JY; Chen SY; Kaplan PL; Hoffer BJ
Stroke; 2001 Sep; 32(9):2170-8. PubMed ID: 11546913
[TBL] [Abstract][Full Text] [Related]
10. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
[TBL] [Abstract][Full Text] [Related]
11. Diadenosine polyphosphates in cultured vascular smooth-muscle cells and endothelium cells--their interaction with specific receptors and their degradation.
Verspohl EJ; Johannwille B; Kaiserling-Buddemeier I; Schlüter H; Hagemann J
J Pharm Pharmacol; 1999 Oct; 51(10):1175-81. PubMed ID: 10579689
[TBL] [Abstract][Full Text] [Related]
12. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
13. Coronary vasomotor and cardiac electrophysiologic effects of diadenosine polyphosphates and nonhydrolyzable analogs in the guinea pig.
Stavrou BM; Lawrence C; Blackburn GM; Cohen T; Sheridan DJ; Flores NA
J Cardiovasc Pharmacol; 2001 May; 37(5):571-84. PubMed ID: 11336108
[TBL] [Abstract][Full Text] [Related]
14. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease.
Ahmad M; Yousuf S; Khan MB; Ahmad AS; Saleem S; Hoda MN; Islam F
Hum Exp Toxicol; 2006 Jul; 25(7):361-8. PubMed ID: 16898164
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.
Crotty S; Fitzgerald P; Tuohy E; Harris DM; Fisher A; Mandel A; Bolton AE; Sullivan AM; Nolan Y
Eur J Neurosci; 2008 Jan; 27(2):294-300. PubMed ID: 18190522
[TBL] [Abstract][Full Text] [Related]
18. Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease.
Du XX; Xu HM; Jiang H; Song N; Wang J; Xie JX
Neurosci Bull; 2012 Jun; 28(3):253-8. PubMed ID: 22622825
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effect of diadenosine tetraphosphate (AP4A) cardioplegia in isolated rat hearts.
Ahmet I; Sawa Y; Nishimura M; Matsuda H
Heart Vessels; 2000; 15(1):30-4. PubMed ID: 11001483
[TBL] [Abstract][Full Text] [Related]
20. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.
Xue YQ; Zhao LR; Guo WP; Duan WM
Neuroscience; 2007 May; 146(3):1245-58. PubMed ID: 17363174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
